- NeoGenomics ( NASDAQ: NEO ) granted its new CEO Chris Smith equity awards.
- The company said Smith will be granted ~336.77K restricted common stock, a sign-on award of ~265.45K restricted stock common, and a stock option to buy ~694.44K common shares, in each case effective as of Aug. 15.
- NeoGenomics added that the inducement awards were made outside of its current equity plan.
- The stock option award has a seven-year term and a per share exercise price of $12.62, representing the closing price of the common stock on the day prior to the stock option award's date of grant.
For further details see:
NeoGenomics grants CEO restricted shares, stock options